Search Results for keywords:"anti-seizure medication"

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for 15 drivers with epilepsy or seizure disorders, allowing them to continue operating commercial motor vehicles (CMVs) in interstate commerce. These exemptions are renewed for two years and come with specific conditions, like staying seizure-free, maintaining stable treatment, and undergoing regular medical checks. If any conditions are violated, the exemption can be revoked. During the exemption period, no state laws contradicting this exemption can be enforced against exempt drivers. This decision aims to maintain a safety level equivalent to current regulations.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to grant exemptions to three individuals with epilepsy or seizure disorders, allowing them to operate commercial motor vehicles across state lines. This decision, effective from January 11, 2021, until January 11, 2023, was based on each individual's medical history and stable treatment regimen. The individuals granted these exemptions have been seizure-free for many years while on medication. The FMCSA believes that this exemption ensures a safety level similar to, or better than, what the standard regulations would achieve.

The Federal Motor Carrier Safety Administration (FMCSA) is allowing 13 people with a history of seizures to drive commercial vehicles under certain conditions. These individuals, who have been seizure-free and have stable treatment plans, are exempt from a rule that generally disqualifies drivers with epilepsy. The exemption is valid for two years and requires these drivers to remain seizure-free, submit annual medical reports, and fulfill additional conditions such as reporting any crashes or citations to FMCSA. The goal is to ensure safety levels equivalent to those of drivers without such medical histories.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for 10 individuals who have a history of epilepsy or seizures. Normally, drivers with such medical history are not allowed to operate commercial motor vehicles (CMVs) in interstate commerce due to safety regulations. However, these exemptions allow the individuals to continue driving as long as they are on anti-seizure medication, ensuring safety is equivalent to standard regulations. The exemptions are valid for two years from their effective date but can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration (FMCSA) is renewing exemptions for 11 individuals with epilepsy or seizure disorders, allowing them to continue driving commercial motor vehicles in interstate commerce. These exemptions make an exception to a Federal Motor Carrier Safety Regulation that generally prohibits such individuals from driving due to safety concerns. Recent evaluations found that these drivers can maintain a safety level equal to or greater than what the law typically requires. The exemptions are valid for two years, provided safety standards are met during that period.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for eight individuals, allowing them to continue driving commercial motor vehicles despite having epilepsy or a history of seizures. These individuals are taking medication for their condition, and FMCSA has determined that the exemptions provide a safety level equal to or greater than the standard regulations. The exemptions are valid for two years, and can be revoked if safety conditions are not met.

The Federal Motor Carrier Safety Administration has received exemption requests from seven individuals who have epilepsy or related conditions. Normally, people with such medical conditions are prohibited from driving commercial vehicles interstate because of risks like seizures. However, these individuals have been seizure-free for many years and are taking or have stopped taking anti-seizure medication. If the exemptions are granted, these individuals would be allowed to drive commercial motor vehicles across state lines. The agency is asking for public comments on these requests by March 25, 2021.

The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation (DOT), has announced a decision to renew a specific medical exemption for 10 truck drivers who have epilepsy or a history of seizures. These drivers, who take anti-seizure medication, are allowed to continue driving commercial vehicles across state lines. FMCSA found that renewing these exemptions maintains or improves safety levels compared to standard regulations. The exemptions are valid for two years unless revoked earlier based on specific conditions not being met.

The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for eight individuals from the rules that usually require interstate commercial motor vehicle (CMV) drivers to have no history or diagnosis of epilepsy or conditions causing loss of consciousness. These exemptions allow drivers who have had seizures but are managing their condition with medication to continue operating CMVs. The renewed exemptions last for two years, provided that the drivers remain seizure-free and adhere to specific regulations. The FMCSA encourages the public to comment on this decision before the specified date, particularly if there are concerns about the drivers' safety records.

The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for seven drivers who have epilepsy or seizure disorders, allowing them to continue driving commercial motor vehicles across state lines. These exemptions, effective from August 31, 2024, to August 31, 2026, were granted after the FMCSA determined that they would maintain or exceed safety standards for drivers. Despite public invitations for comments, no feedback was received during the review periods. Each exemption will last two years unless revoked due to non-compliance, decreased safety, or inconsistency with regulatory goals.